Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines
- PMID: 35243679
- PMCID: PMC9111132
- DOI: 10.1111/1346-8138.16347
Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines
Abstract
Drug-induced hypersensitivity syndrome (DiHS) is a severe drug eruption that can induce reactivation of herpesviruses such as human herpesvirus 6, resulting in symptom flare-up and organ damage. DiHS is known as drug reaction with eosinophilia and systemic symptoms (DRESS) in Europe. We report three cases of DiHS that could have been triggered by mRNA-based coronavirus disease 2019 (COVID-19) vaccines. In these three patients, symptoms of DiHS developed 2-6 days after the first dose of an mRNA-based COVID-19 vaccine. Although there have been no reports of DiHS/DRESS induced by mRNA-based COVID-19 vaccines in domestic and international journals despite the progress in vaccination worldwide, we speculate that mRNA-based COVID-19 vaccines might have triggered the development of DiHS/DRESS in our patients. In the current coronavirus epidemic, it might be important to assess mRNA-based COVID-19 vaccination status and date of vaccination when evaluating a patient with DiHS/DRESS.
Keywords: coronavirus disease 2019; drug-induced hypersensitivity syndrome; human herpesvirus 6; mRNA; vaccine.
© 2022 Japanese Dermatological Association.
Conflict of interest statement
None declared.
Figures


References
-
- Shiohara T, Mizukawa Y. Drug‐induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68:301–8. - PubMed
-
- Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2019;80:670–8. - PubMed
-
- Mehrholz D, Urban AE, Herstowska M, Nowicki R, Cubała W, Barańska‐Rybak W. A retrospective study of DRESS ‐ drug reaction with eosinophilia and systemic symptoms. Psychiatr Pol. 2017;51:1079–93. - PubMed
-
- Hewitt N, Levinson M, Stephenson G. Drug reaction with eosinophilia and systemic symptoms associated with H1N1 vaccination. Intern Med J. 2012;42:1365–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical